AlzProtect SAS
🇫🇷France
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Study to Assess Tolerability, Safety, Pharmacokinetics and Effect of AZP2006 in Patients With PSP
Phase 2
Completed
- Conditions
- Progressive Supranuclear Palsy
- Interventions
- Drug: Placebo oral solutionDrug: AZP2006 oral solution
- First Posted Date
- 2019-07-05
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- AlzProtect SAS
- Target Recruit Count
- 36
- Registration Number
- NCT04008355
- Locations
- 🇫🇷
Hôpital Salengro, Lille, Hauts De France, France
🇫🇷Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Paris, Ile-de-France, France
🇫🇷Hôpital de la Fondation Adolphe de Rothschild, Paris, France
News
No news found